Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
K-757 by Kallyope for Obesity: Likelihood of Approval
K-757 is under clinical development by Kallyope and currently in Phase II for Obesity. According to GlobalData, Phase II drugs...
Data Insights
K-757 by Kallyope for Obesity: Likelihood of Approval
K-757 is under clinical development by Kallyope and currently in Phase II for Obesity. According to GlobalData, Phase II drugs...